|
|
|
|
Validation of the murine aortic arch as a model to study human vascular diseases
Although the murine thoracic aorta and its main branches are widely studied to gain more insight into the pathogenesis of human vascular diseases, detailed anatomical data on the murine aorta are sparse.Moreover, comparative studies between mice and...
|
|
|
New guidelines aim to prevent unnecessary death from thoracic aortic disease
Cardiovascular Diseases Breaking News EUREKALERT Contact: Amanda Jekowsky 202-731-3069 Multidisciplinary team of experts weighs in on diagnosis and management When actor John Ritter died suddenly in 2003 from a tear in his thoracic aortathe large artery that...
|
|
|
PERSEUS Trial Shows Strong Results for Platinum Chromium Stent System
Results from the PERSEUS clinical program demonstrate positive safety and efficacy outcomes in workhorse lesions for a new platinum chromium stent system.The 12-month results studied Boston Scientific Corp.'s Taxus Element Paclitaxel-Eluting Stent System...
|
|
|
SPIRIT Results Show Continued Positive Results Market-Leading Stent
New data released at the American College of Cardiology Scientific Session this week showed continued positive clinical results for the Xience V everolimus-eluting coronary stent.Four-year results from the SPIRIT II trial were presented by Yoshinobu Onuma, M...
|
|
|
Timothy Hla Appointed to Lead Center for Vascular Biology at Weill Cornell Medical College
Source: NewYork-Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College Newswise One of the nation's foremost vascular biologists, Dr.Timothy T. Hla, has been appointed as the new director of the Center for Vascular...
|
|
|
Impotence 'a sign of heart problems'
'Impotence is a strong predictor of heart attack and death among men who already have heart disease,' says the BBC.The news is based on a well-conducted international study of 1,519 men with cardiovascular disease. The study found that those who had...
|
|
|
Surgical specialty impacts CEA outcomes
MedWire News: Patients undergoing carotid endarterectomy (CEA) have better long-term outcomes if their operation is performed by a vascular specialist, research suggests.Christopher Hollenbeak (Penn State College of Medicine, Hershey, USA) and...
|
|
|
TopAbstracts in Vascular Disorders 03/18/2010
TopAbstracts in Vascular Disorders are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide newsletter or visited a website Powered by Doctor's Guide in the past 14 days.Over 2000 peer-reviewed journals...
|
|
|
Stem cells used to model infant birth defect
Hemangiomas -- strawberry-like birthmarks that commonly develop in early infancy -- are generally harmless, but up to 10 percent cause tissue distortion or destruction and sometimes obstruction of vision or breathing.Since the 1960s, problematic hemangiomas...
|
|
|
Cedars-Sinai Heart Institute Physicians Present Findings At American College Of Cardiology Scientific Meeting
Physician scientists from the Cedars-Sinai Heart Institute presented new findings on the effectiveness of routine aspirin therapy for preventing heart disease, a drug therapy for atrial fibrillation and the role left ventricular assist devices (LVADs) may play...
|
|
|
Stem Cells Used To Model Infant Birth Defect
Hemangiomas -- strawberry-like birthmarks that commonly develop in early infancy -- are generally harmless, but up to 10 percent cause tissue distortion or destruction and sometimes obstruction of vision or breathing.Since the 1960s, problematic hemangiomas...
|
|
|
Study shows that steroids target hemangioma stem cells
Hemangiomas -- strawberry-like birthmarks that commonly develop in early infancy - are generally harmless, but up to 10 percent cause tissue distortion or destruction and sometimes obstruction of vision or breathing.Since the 1960s, problematic hemangiomas...
|
|
|
Physician scientists present new findings on aspirin therapy, atrial fibrillation drug therapy and LVAD
Physician scientists from the Cedars-Sinai Heart Institute presented new findings on the effectiveness of routine aspirin therapy for preventing heart disease, a drug therapy for atrial fibrillation and the role left ventricular assist devices (LVADs) may play...
|
|
|
Abbott Labs Dividend Stock Analysis
9, 00 Filed Under: Author: Dividend Growth InvestorFollow followingMore about : Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide.It operates in four segments: Pharmaceutical Products,...
|
|
|
FDA Advisory Panel Unanimously Recommends Expanded Indication for Boston Scientific's Heart Failure Devices Ba
NATICK, Mass., March 18 /PRNewswire-FirstCall/ Boston Scientific Corporation (NYSE: BSX) today announced that the Circulatory System Devices Panel of the U.S.Food and Drug Administration (FDA) has unanimously recommended approval of an expanded indication...
|
|
|
FDA Advisory Panel Unanimously Recommends Expanded Indication for Boston Scientific's Heart Failure Devices Based on Landmark MADIT-CRT Trial
NATICK, Mass., March 18 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that the Circulatory System Devices Panel of the U.S.Food and Drug Administration (FDA) has unanimously recommended approval of an expanded indication...
|
|
|
Aqueous Humor and Plasma Levels of Vascular Endothelial Growth Factor and Nitric Oxide in Patients With Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma
Borazan M et al.Elevated aqueous humor VEGF and NO levels and plasma VEGF concentrations in eyes with PXS and PXG can be explained by the ischemic nature of these disorders. Aqueous Humor and Plasma Levels of Vascular Endothelial Growth Factor and...
|
|
|
Abbott Labs: Dividend Stock Analysis
Dobromir Stoyanov submits: Abbott Laboratories ( ABT ) engages in the discovery, development, manufacture, and sale of health care products worldwide.It operates in four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and ...
|
|
|
Medafor Informs CryoLife that CryoLife Has Repudiated the Exclusive Distribution Agreement
MINNEAPOLIS-- (BUSINESS WIRE) -- Medafor Inc.said today that it sent a letter to CryoLife, Inc. (NYSE: CRY), informing the Company that by CryoLifes failure to provide adequate assurance that it would properly perform its obligations under the two...
|
|
|
FDA approves expanded indication for Boston Scientific's CRT-Ds
Boston Scientific Corporation (NYSE: BSX) today announced that the Circulatory System Devices Panel of the U.S.Food and Drug Administration (FDA) has unanimously recommended approval of an expanded indication for its cardiac resynchronization therapy...
|
|
|
Low-risk group has high prevalence of abnormal ankle-brachial index
NEW YORK (Reuters Health) - A screening population without cardiovascular disease or diabetes had roughly a 14% prevalence of abnormal ankle-brachial index (ABI), investigators reported this week.Many of those with an abnormal ABI were categorized as "low...
|
|
|
Impotence 'a sign of heart problems'
<div><p><p>Impotence is a strong predictor of heart attack and death among men who already have heart disease, says the BBC.</p> <p>The news is based on a well-conducted international study of 1,519 men with cardiovascular disease....
|
|
|
Stem Cells Used to Model Infant Birth Defect
Hemangiomas -- strawberry-like birthmarks that commonly develop in early infancy -- are generally harmless, but up to 10 percent cause tissue distortion or destruction and sometimes obstruction of vision or breathing.Since the 1960s, problematic hemangiomas...
|
|
|
Cedars-Sinai Heart Institute Physicians Present Findings at American College of Cardiology Scientific Meeting
Source: Cedars-Sinai Medical Center Newswise Physician scientists from the Cedars-Sinai Heart Institute presented new findings on the effectiveness of routine aspirin therapy for preventing heart disease, a drug therapy for atrial fibrillation and the role left...
|
|
|
Cedars-Sinai Heart Institute physicians present findings at ACC scientific meeting
LOS ANGELES Physician scientists from the Cedars-Sinai Heart Institute presented new findings on the effectiveness of routine aspirin therapy for preventing heart disease, a drug therapy for atrial fibrillation and the role left ventricular assist devices ...
|
